Form 8-K - Current report:
SEC Accession No. 0000950170-22-011172
Filing Date
2022-06-03
Accepted
2022-06-03 16:32:03
Documents
12
Period of Report
2022-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K acet-20220602.htm   iXBRL 8-K 78984
  Complete submission text file 0000950170-22-011172.txt   204339

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20220602.xsd EX-101.SCH 2472
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20220602_lab.xml EX-101.LAB 14564
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20220602_pre.xml EX-101.PRE 10679
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20220602_htm.xml XML 5165
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 22995019
SIC: 2834 Pharmaceutical Preparations